FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wiek van Gilst

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Anatomy

Concepts & Ideas

Risk Factors

Procedures

Double-Blind Method

Physiology

Co-author Network

Publications

TOP 3
Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J.L. Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Dirk J van Veldhuisen; Adriaan A Voors; Arno W Hoes; Tiny Jaarsma; Gerard C M Linssen; Walter J Paulus; Jan G P Tijssen; Wiek H van Gilst; Hans L Hillege
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
Hasan Mahmud; Willem P T Ruifrok; Herman H W Silljé; Wiek H van Gilst; Inge Vreeswijk-Baudoin; B Daan Westenbrink; Megan V Cannon; Rudolf A de Boer
Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wiek van Gilst (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J.L. Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
European heart journal 2013;34(19):1424-31.
2013: Dirk J van Veldhuisen; Adriaan A Voors; Arno W Hoes; Tiny Jaarsma; Gerard C M Linssen; Walter J Paulus; Jan G P Tijssen; Wiek H van Gilst; Hans L Hillege
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
Journal of the American College of Cardiology 2013;61(14):1498-506.
2013: Hasan Mahmud; Willem P T Ruifrok; Herman H W Silljé; Wiek H van Gilst; Inge Vreeswijk-Baudoin; B Daan Westenbrink; Megan V Cannon; Rudolf A de Boer
Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia.
Cardiovascular research 2013;98(1):37-46.
2013: Niek Verweij; Hongjuan Yu; Wiek H van Gilst; Dirk J van Veldhuisen; Folkert W Asselbergs; Stephan J L Bakker; Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Hasan Mahmud; Irene Mateo Leach; Patricia B Munroe; Herman H W Silljé; Joachim Struck; Pim van der Harst
Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1.
Hypertension 2013;61(3):602-8.
2013: Lili Yu; Ruud A Bank; Eelke M. Bos; Irwin J Goldstein; Jasper A Koerts; Maxi Meissner; Bertram Pitt; Willem P T Ruifrok; Bahram Sanjabi; Herman H W Silljé; Pim van der Harst; Wiek H van Gilst; Harry van Goor; Dirk J van Veldhuisen; Rudolf A de Boer
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Circulation. Heart failure 2013;6(1):107-17.
2012: Frank P Brouwers; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective.
Current heart failure reports 2012;9(4):363-8.
2012: Laura M G Meems; Willem P T Ruifrok; Herman H W Silljé; Wiek H van Gilst; Adriaan A Voors; Megan V Cannon; Hasan Mahmud; Rudolf A de Boer
The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
The Journal of steroid biochemistry and molecular biology 2012;132(3-5):282-9.
2012: Thomas F Lüscher; Frank Ruschitzka; Wiek H van Gilst; Ulf Landmesser; Adriaan A Voors; Dirk J van Veldhuisen
The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing.
European journal of heart failure 2012;14(10):1075-82.
2012: Frank P Brouwers; Rudolf A de Boer; Paul E de Jong; Dick de Zeeuw; Rijk O Gans; Ron T Gansevoort; Hans L Hillege; Joachim Struck; Pim van der Harst; Wiek H van Gilst; Stephan J.L. Bakker
Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.
Heart (British Cardiac Society) 2012;98(18):1348-53.
2012: Rudolf A de Boer; Ron T Gansevoort; Stephan J L Bakker; Hasan Mahmud; Nicolas F Schroten; Mariusz K Szymanski; Pim van der Harst; Wiek H van Gilst; Dirk J van Veldhuisen; Hans L Hillege
Plasma renin and outcome in the community: data from PREVEND.
European heart journal 2012;33(18):2351-9.
2012: Lennaert Kleijn; Wiek H van Gilst; Adriaan A Voors; Dirk J van Veldhuisen; Anne M S Belonje; Rudolf A de Boer; Sudip Ghosh; Hans L Hillege; Tiny Jaarsma; Joseph Kim; Peter van der Meer
Inflammation and anaemia in a broad spectrum of patients with heart failure.
Heart (British Cardiac Society) 2012;98(16):1237-41.
2012: Mariusz K Szymanski; Wiek H van Gilst; Rudolf A de Boer; Gerjan J Navis; Hans L Hillege
Animal models of cardiorenal syndrome: a review.
Heart failure reviews 2012;17(3):411-20.
2012: Bo Lu; Willem P Ruifrok; Wiek H van Gilst; Hongjuan Yu; Maarten Zwartbol; Rudolf A de Boer; Herman H W Silljé
Identification of hypertrophy- and heart failure-associated genes by combining in vitro and in vivo models.
Physiological genomics 2012;44(8):443-54.
2012: Hasan Mahmud; Herman H W Silljé; Wiek H van Gilst; Megan V Cannon; Rudolf A de Boer
Regulation of the (pro)renin-renin receptor in cardiac remodelling.
Journal of cellular and molecular medicine 2012;16(4):722-9.
2012: Yumei Wang; Leo E Deelman; Hans-Peter Hammes; Robert H Henning; Sjoerd Landheer; Aart van Amerongen; Wiek H van Gilst; Hendrik Buikema
Attenuation of renovascular damage in Zucker diabetic fatty rat by NWT-03, an egg protein hydrolysate with ACE- and DPP4-inhibitory Activity.
PloS one 2012;7(10):e46781.
2012: Rudolf A de Boer; Lude Franke; Ron T Gansevoort; Irene Mateo Leach; Anneke C Muller Kobold; Wiek H van Gilst; Dirk J van Veldhuisen; Niek Verweij; Harm-Jan Westra; Stephan J L Bakker; Pim van der Harst
A genome-wide association study of circulating galectin-3.
PloS one 2012;7(10):e47385.
2011: Beatrijs Bartelds; Bibiche Boersma; Marinus A Borgdorff; Leon J De Windt; Nynke J Elzenga; Marcel G Nederhoff; Annemiek Smit-van Oosten; Janny Takens; Wiek H van Gilst; Rolf M F Berger
Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load.
European journal of heart failure 2011;13(12):1275-82.
2011: B Daan Westenbrink; Richard Baillot; Rudolf A de Boer; Lennaert Kleijn; Jean L Rouleau; Jan G Tijssen; Wiek H van Gilst; Wayne J Warnica
Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: insights from the IMAGINE trial.
Heart (British Cardiac Society) 2011;97(19):1590-6.
2011: Mariusz K Szymanski; Wiek H van Gilst; Dirk J van Veldhuisen; Kevin Damman; Hans L Hillege; Rudolf A de Boer
Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.
American heart journal 2011;162(3):487-93.
2011: Frank P Brouwers; Folkert Asselbergs; Hans L Hillege; Rudolf A de Boer; Ron T Gansevoort; Dirk J van Veldhuisen; Wiek H van Gilst
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
American heart journal 2011;161(6):1171-8.
2011: Licette C Y Liu; Adriaan Voors; Dirk J van Veldhuisen; Eveline van der Veer; Anne M Belonje; Mariusz K Szymanski; Herman H W Silljé; Wiek H van Gilst; Tiny Jaarsma; Rudolf A de Boer
Vitamin D status and outcomes in heart failure patients.
European journal of heart failure 2011;13(6):619-25.
2011: Jardi Huzen; Wouter Peeters; Rudolf A de Boer; Frans L Moll; Liza S M Wong; Veryan Codd; Dominique P V de Kleijn; Bart J G L de Smet; Dirk J van Veldhuisen; Nilesh J Samani; Wiek H van Gilst; Gerard Pasterkamp; Pim van der Harst
Circulating leukocyte and carotid atherosclerotic plaque telomere length: interrelation, association with plaque characteristics, and restenosis after endarterectomy.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(5):1219-25.
2011: Willem-Peter T Ruifrok; Cheng Qian; Herman H W Silljé; Harry van Goor; Dirk J van Veldhuisen; Wiek H van Gilst; Rudolf A de Boer
Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin.
Journal of molecular medicine (Berlin, Germany) 2011;89(4):377-87.
2011: Anne Margreet De Jong; Alexander H Maass; Silke U Oberdorf-Maass; Dirk J van Veldhuisen; Wiek H van Gilst; Isabelle C Van Gelder
Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.
Cardiovascular research 2011;89(4):754-65.
2011: Meimei Yin; Maxi Meissner; Herman H W Silljé; Wiek H van Gilst; Rudolf A de Boer
Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure.
Cardiovascular diabetology 2011;10():85.
2011: Liza S M Wong; Rudolf A de Boer; Jardi Huzen; Wiek H van Gilst; Dirk J van Veldhuisen; Pim van der Harst
Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring.
PloS one 2011;6(8):e23118.
2011: Christopher S Coffey; Folkert W Asselbergs; Patricia R Hebert; Hans L Hillege; Qing Li; Jason H Moore; Wiek H van Gilst
The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels.
Cardiology research and practice 2011;2011():541467.
2010: Adriaan A Voors; Anne M S Belonje; Felix Zijlstra; Hans L Hillege; Stefan D Anker; Riemer H J A Slart; René A Tio; Arnoud W J van 't Hof; J Wouter Jukema; Hans Otto J Peels; José P S Henriques; Jurriën M ten Berg; Jeroen Vos; Wiek H van Gilst; Dirk J van Veldhuisen
A single dose of erythropoietin in ST-elevation myocardial infarction.
European heart journal 2010;31(21):2593-600.
2010: Irma Kuipers; Jiang Li; Inge Vreeswijk-Baudoin; Johan Koster; Pim van der Harst; Herman H W Silljé; Folkert Kuipers; Dirk J van Veldhuisen; Wiek H van Gilst; Rudolf A de Boer
Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo.
European journal of heart failure 2010;12(10):1042-50.
2010: Dirk J van Veldhuisen; Adriaan A Voors; Wiek H van Gilst
The European Journal of Heart Failure in 2010: current impact factor, time-to-first decision, and number of submissions.
European journal of heart failure 2010;12(9):895-7.
2010: Katy J L Bell; Andrew Hayen; Petra Macaskill; Jonathan C Craig; Bruce Neal; Kim M Fox; Willem J Remme; Folkert W Asselbergs; Wiek H van Gilst; Stephen MacMahon; Giuseppe Remuzzi; Piero Ruggenenti; Koon K Teo; Les Irwig
Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials.
Hypertension 2010;56(3):533-9.
2010: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Jardi Huzen; Wiek H van Gilst; Dirk J van Veldhuisen
Aging, telomeres and heart failure.
Heart failure reviews 2010;15(5):479-86.
2010: Willem-Peter T Ruifrok; Erik Lipsic; Rudolf A de Boer; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoiesis stimulation in acute ischemic syndromes.
Heart failure clinics 2010;6(3):313-21.
2010: Hisko Oeseburg; Rudolf A de Boer; Hendrik Buikema; Pim van der Harst; Wiek H van Gilst; Herman H W Silljé
Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(7):1407-14.
2010: B Daan Westenbrink; Adriaan Voors; Rudolf A de Boer; Jan Jacob Schuringa; Theo Klinkenberg; Pim van der Harst; Edo Vellenga; Dirk J van Veldhuisen; Wiek H van Gilst
Bone marrow dysfunction in chronic heart failure patients.
European journal of heart failure 2010;12(7):676-84.
2010: B Daan Westenbrink; Willem-Peter T Ruifrok; Adriaan A Voors; Ronald G Tilton; Dirk J van Veldhuisen; Regien G Schoemaker; Wiek H van Gilst; Rudolf A de Boer
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Cardiovascular research 2010;87(1):30-9.
2010: W T Ruifrok; B Daan Westenbrink; Rudolf A de Boer; I J den Hamer; Michiel E Erasmus; HE Mungroop; Anne H Epema; Adriaan Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2010;18(5):236-42.
2010: Liza S M Wong; Jardi Huzen; Pim van der Harst; Rudolf A de Boer; Veryan Codd; B Daan Westenbrink; Germaine F J D Benus; Adriaan A Voors; Wiek H van Gilst; Nilesh J Samani; Tiny Jaarsma; Dirk J van Veldhuisen
Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure.
European journal of heart failure 2010;12(4):348-53.
2010: Irma Kuipers; Pim van der Harst; Folkert Kuipers; Linda van Genne; Maaike Goris; Jukka Y Lehtonen; Dirk J van Veldhuisen; Wiek H van Gilst; Rudolf A de Boer
Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system.
Laboratory investigation; a journal of technical methods and pathology 2010;90(4):630-6.
2010: Martje H L van der Wal; Tiny Jaarsma; Debra Moser; Wiek H van Gilst; Dirk J van Veldhuisen
Qualitative examination of compliance in heart failure patients in The Netherlands.
Heart & lung : the journal of critical care 2010;39(2):121-30.
2010: Veryan Codd; Massimo Mangino; Pim van der Harst; Peter S Braund; Michael Kaiser; Alan J Beveridge; Suzanne Rafelt; Jasbir Moore; Chris Nelson; Nicole Soranzo; Guangju Zhai; Ana M Valdes; Hannah Blackburn; Irene Mateo Leach; Rudolf A de Boer; Alison H Goodall; Willem Ouwehand; Dirk J van Veldhuisen; Wiek H van Gilst; gerjan navis; Paul R Burton; Martin D Tobin; Alistair Hall; John R Thompson; Tim Spector; Abraham Aviv; Masayuki Kimura; Nilesh J Samani
Common variants near TERC are associated with mean telomere length.
Nature genetics 2010;42(3):197-9.
2010: Yong Wang; Cheng Qian; Anton J M Roks; Dirk Westermann; Sarah-Mai Schumacher; Felicitas Escher; Regien G Schoemaker; Timothy L Reudelhuber; Wiek H van Gilst; Heinz-Peter Schultheiss; Carsten Tschöpe; Thomas Walther
Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction.
Circulation. Heart failure 2010;3(2):286-93.
2010: Jardi Huzen; Pim van der Harst; Rudolf A de Boer; Ivonne Lesman-Leegte; Adriaan A Voors; Wiek H van Gilst; Nilesh J Samani; Tiny Jaarsma; Dirk J van Veldhuisen
Telomere length and psychological well-being in patients with chronic heart failure.
Age and ageing 2010;39(2):223-7.
2010: Ruben Coronel; Jorina Langerveld; Lucas V A Boersma; Eric F D Wever; Laurens Bon; Pascal F H M van Dessel; André C Linnenbank; Wiek H van Gilst; Sjef M P G Ernst; Tobias Opthof; Norbert M van Hemel
Left atrial pressure reduction for mitral stenosis reverses left atrial direction-dependent conduction abnormalities.
Cardiovascular research 2010;85(4):711-8.
2010: Anne M S Belonje; Adriaan A Voors; peter van der meer; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Endogenous erythropoietin and outcome in heart failure.
Circulation 2010;121(2):245-51.
2010: Bo Lu; Hasan Mahmud; Alexander H Maass; Bo Yu; Wiek H van Gilst; Rudolf A de Boer; Herman H W Silljé
The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro.
PloS one 2010;5(9):e12963.
2010: John P Bentley; Folkert W Asselbergs; Christopher S Coffey; Patricia R Hebert; Jason H Moore; Hans L Hillege; Wiek H van Gilst
Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems.
PloS one 2010;5(9):e12757.
2010: Jardi Huzen; Rudolf A de Boer; Dirk J van Veldhuisen; Wiek H van Gilst; Pim van der Harst
The emerging role of telomere biology in cardiovascular disease.
Frontiers in bioscience : a journal and virtual library 2010;15():35-45.
2010: Pim van der Harst; Rudolf A de Boer; Nilesh J Samani; Liza S M Wong; Jardi Huzen; Veryan Codd; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Telomere length and outcome in heart failure.
Annals of medicine 2010;42(1):36-44.
2010: Hisko Oeseburg; Rudolf A de Boer; Wiek H van Gilst; Pim van der Harst
Telomere biology in healthy aging and disease.
Pflügers Archiv : European journal of physiology 2010;459(2):259-68.
2009: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Veryan Codd; Jardi Huzen; Nilesh J Samani; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Renal dysfunction is associated with shorter telomere length in heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(10):629-34.
2009: Rudolf A de Boer; Adriaan A Voors; Pieter Muntendam; Wiek H van Gilst; Dirk J van Veldhuisen
Galectin-3: a novel mediator of heart failure development and progression.
European journal of heart failure 2009;11(9):811-7.
2009: Bernadet D M Meijering; Lynda J M Juffermans; Annemieke van Wamel; Robert H Henning; Inge S Zuhorn; Marcia Emmer; Amanda M G Versteilen; Walter J Paulus; Wiek H van Gilst; Klazina Kooiman; Nico de Jong; René J P Musters; Leo E Deelman; Otto Kamp
Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation.
Circulation research 2009;104(5):679-87.
2009: Ying Xu; Robert H Henning; Maria Sandovici; Johannes van der Want; Wiek H van Gilst; Hendrik Buikema
Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function.
European journal of heart failure 2009;11(3):246-55.
2009: Cheng Qian; Regien G Schoemaker; Wiek H van Gilst; Anton J M Roks
The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Clinical science (London, England : 1979) 2009;116(4):301-14.
2009: Hisko Oeseburg; Dilek Iusuf; Pim van der Harst; Wiek H van Gilst; Robert H Henning; Anton J M Roks
Bradykinin protects against oxidative stress-induced endothelial cell senescence.
Hypertension 2009;53(2):417-22.
2009: Liza S M Wong; Hisko Oeseburg; Rudolf A de Boer; Wiek H van Gilst; Dirk J van Veldhuisen; Pim van der Harst
Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing.
Cardiovascular research 2009;81(2):244-52.
2009: Bart Westendorp; I Hamming; Mariusz K Szymanski; gerjan navis; Harry van Goor; Hendrik Buikema; Wiek H van Gilst; Regien G Schoemaker
Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor.
European journal of pharmacology 2009;602(2-3):373-9.
2009: Nadir Ulu; Regien G Schoemaker; Robert H Henning; Hendrik Buikema; Tom Teerlink; Freek J Zijlstra; Stephan J L Bakker; Wiek H van Gilst; gerjan navis
Proteinuria-associated endothelial dysfunction is strain dependent.
American journal of nephrology 2009;30(3):209-17.
2009: Nadir Ulu; Rob H Henning; Maaike Goris; Regien G Schoemaker; Wiek H van Gilst
Effects of ivabradine and metoprolol on cardiac angiogenesis and endothelial dysfunction in rats with heart failure.
Journal of cardiovascular pharmacology 2009;53(1):9-17.
2008: C Qian; R G Schoemaker; Wiek H van Gilst; B Yu; A J M Roks
Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 2: Pharmacological targets, agents and intervention perspectives.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(10):337-43.
2008: Tiny Jaarsma; M H L van der Wal; Ivonne Lesman-Leegte; Marie Louise Luttik; Jochem Hogenhuis; N J Veeger; Robbert Sanderman; Arno Hoes; Wiek H van Gilst; D J A Lok; P H J M Dunselman; J G P Tijssen; Hans L Hillege; Dirk J van Veldhuisen
[Value of basic and intensive management of patients with heart failure; results of a randomised controlled clinical trial].
Nederlands tijdschrift voor geneeskunde 2008;152(37):2016-21.
2008: C Qian; R G Schoemaker; Wiek H van Gilst; B Yu; A J M Roks
Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor cells, their functions and sources.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(9):305-9.
2008: Bas Langeveld; Robert H Henning; Bart J G L de Smet; Felix Zijlstra; A Driessen; E Tijsma; Wiek H van Gilst; Anton J M Roks
Rescue of arterial function by angiotensin-(1-7): towards improvement of endothelial function by drug-eluting stents.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(9):291-2.
2008: B Daan Westenbrink; Hisko Oeseburg; Lennaert Kleijn; Pim van der Harst; Anne M S Belonje; Adriaan A Voors; Regien G Schoemaker; Rudolf A de Boer; Dirk J van Veldhuisen; Wiek H van Gilst
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(4):265-74.
2008: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
The American journal of cardiology 2008;102(2):223-5.
2008: Pim van der Harst; Liza S M Wong; Rudolf A de Boer; Scott Brouilette; Gerrit van der Steege; Adriaan A Voors; Alistair Hall; Nilesh J Samani; John Wikstrand; Wiek H van Gilst; Dirk J van Veldhuisen
Possible association between telomere length and renal dysfunction in patients with chronic heart failure.
The American journal of cardiology 2008;102(2):207-10.
2008: peter van der meer; Dirk J Lok; James L Januzzi; Pieta W Bruggink-Andre de la Porte; Erik Lipsic; Jan van Wijngaarden; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.
European heart journal 2008;29(12):1510-5.
2008: Irma Kuipers; Pim van der Harst; gerjan navis; Linda van Genne; Fulvio Morello; Wiek H van Gilst; Dirk J van Veldhuisen; Rudolf A de Boer
Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system.
Hypertension 2008;51(6):1442-8.
2008: Nadir Ulu; Hendrik Buikema; Wiek H van Gilst; gerjan navis
Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(6):1854-60.
2008: J Huzen; Dirk J van Veldhuisen; Wiek H van Gilst; Pim van der Harst
[Telomeres and biological ageing in cardiovascular disease].
Nederlands tijdschrift voor geneeskunde 2008;152(22):1265-70.
2008: Hendrik C Groenewegen; Pim van der Harst; Anton J M Roks; Hendrik Buikema; Felix Zijlstra; Wiek H van Gilst; Bart J G L de Smet
Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation.
International journal of cardiology 2008;126(2):209-15.
2008: Ying Xu; Hendrik Buikema; Wiek H van Gilst; Robert H Henning
Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease.
European journal of pharmacology 2008;585(2-3):256-60.
2008: Dilek Iusuf; Robert H Henning; Wiek H van Gilst; Anton J M Roks
Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.
European journal of pharmacology 2008;585(2-3):303-12.
2008: Willem-Peter T Ruifrok; Rudolf A de Boer; B Daan Westenbrink; Dirk J van Veldhuisen; Wiek H van Gilst
Erythropoietin in cardiac disease: new features of an old drug.
European journal of pharmacology 2008;585(2-3):270-7.
2008: Anne M Belonje; Adriaan A Voors; Wiek H van Gilst; Stefan D Anker; Riemer H J A Slart; Rene A Tio; Felix Zijlstra; Dirk J van Veldhuisen
Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III).
American heart journal 2008;155(5):817-22.
2008: B Daan Westenbrink; Rudolf A de Boer; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Anemia in chronic heart failure: etiology and treatment options.
Current opinion in cardiology 2008;23(2):141-7.
2008: Sidney Chocron; Richard Baillot; Jean-Lucien Rouleau; Wayne J Warnica; Pierre Block; David Johnstone; Martin G Myers; Cristina Dana Calciu; Anna Nozza; Pierre Martineau; Wiek H van Gilst
Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.
European heart journal 2008;29(5):673-9.
2008: Pim van der Harst; Michael Böhm; Wiek H van Gilst; Dirk J van Veldhuisen
The case for statin therapy in chronic heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(3):139-46.
2008: Tiny Jaarsma; Martje H L van der Wal; Ivonne Lesman-Leegte; Marie Louise Luttik; Jochem Hogenhuis; Nic J G M Veeger; Robbert Sanderman; Arno Hoes; Wiek H van Gilst; Dirk J A Lok; Peter H J M Dunselman; Jan G P Tijssen; Hans L Hillege; Dirk J van Veldhuisen
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
Archives of internal medicine 2008;168(3):316-24.
2008: Pim van der Harst; Hendrik C Groenewegen; Anton J M Roks; Hendrik Buikema; Felix Zijlstra; Wiek H van Gilst; Bart J G L de Smet
Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
Coronary artery disease 2008;19(1):47-53.
2008: peter van der meer; Erik Lipsic; Wiek H van Gilst; Dirk J van Veldhuisen
Anemia and erythropoietin in heart failure.
Heart failure monitor 2008;6(1):28-33.
2008: Hendrik C Groenewegen; Geanina Onuta; Maaike Goris; André Zandvoort; Felix Zijlstra; Wiek H van Gilst; Jan Rozing; Bart J G L de Smet; Anton J M Roks; Jan-Luuk Hillebrands
Non-bone marrow origin of neointimal smooth muscle cells in experimental in-stent restenosis in rats.
Journal of vascular research 2008;45(6):493-502.
2008: Folkert Asselbergs; M P van den Berg; Stephan J.L. Bakker; J E Signorovitch; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(3):73-8.
2008: Erik Lipsic; B Daan Westenbrink; peter van der meer; Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen; Regien G Schoemaker; Wiek H van Gilst
Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.
European journal of heart failure 2008;10(1):22-9.
2008: Jean-Lucien Rouleau; Wayne J Warnica; Richard Baillot; Pierre J Block; Sidney Chocron; David Johnstone; Martin G Myers; Cristina-Dana Calciu; Sonia Dalle-Ave; Pierre Martineau; Christine Mormont; Wiek H van Gilst
Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Circulation 2008;117(1):24-31.
2008: Christiane A Geluk; Wendy J Post; Hans L Hillege; René A Tio; Jan G P Tijssen; RB van Dijk; W Arnold Dijk; Stephan J L Bakker; Paul E de Jong; Wiek H van Gilst; Felix Zijlstra
C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort.
Atherosclerosis 2008;196(1):372-82.
2008: Folkert Asselbergs; Pim van der Harst; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Andries J Smit; Wiek H van Gilst
Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects.
Atherosclerosis 2008;196(1):349-55.
2007: Ruud M A van de Wal; Pim van der Harst; Wim Gerritsen; Fal van der Horst; Thijs H W Plokker; Ron T Gansevoort; Wiek H van Gilst; Adriaan A Voors
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2007;8(4):177-80.
2007: Bernadet D M Meijering; Robert H Henning; Wiek H van Gilst; Ivana Gavrilovic; Annemieke van Wamel; Leo E Deelman
Optimization of ultrasound and microbubbles targeted gene delivery to cultured primary endothelial cells.
Journal of drug targeting 2007;15(10):664-71.
2007: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Stephan J L Bakker; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.
The American journal of cardiology 2007;100(10):1548-51.
2007: Hisko Oeseburg; B Daan Westenbrink; Rudolf A de Boer; Wiek H van Gilst; Dirk J van Veldhuisen; Pim van der Harst
Can critically short telomeres cause functional exhaustion of progenitor cells in postinfarction heart failure?
Journal of the American College of Cardiology 2007;50(19):1911-2; author reply 1912-3.
2007: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; Harold Snieder; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
The effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context.
Human genetics 2007;122(3-4):275-81.
2007: Ruud M A van de Wal; Pim van der Harst; Lodewijk J Wagenaar; Sven Wassmann; Wim J Morshuis; G Nickenig; Hendrik Buikema; H W M Plokker; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
Journal of cardiovascular pharmacology 2007;50(4):372-9.
2007: Tom D J Smilde; Mike W Zuurman; Hans L Hillege; Dirk J van Veldhuisen; Wiek H van Gilst; Gerrit van der Steege; Adriaan A Voors; Jan A Kors; Paul E de Jong; gerjan navis
Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
American journal of hypertension 2007;20(10):1097-103.
2007: Anne M S Belonje; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin in chronic heart failure.
Congestive heart failure (Greenwich, Conn.) 2007;13(5):289-92.
2007: B Daan Westenbrink; Adriaan A Voors; Willem-Peter T Ruifrok; Wiek H van Gilst; Dirk J van Veldhuisen
Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.
Current heart failure reports 2007;4(3):127-33.
2007: B Daan Westenbrink; Erik Lipsic; peter van der meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
European heart journal 2007;28(16):2018-27.
2007: Martje H L van der Wal; Tiny Jaarsma; Debra Moser; Wiek H van Gilst; Dirk J van Veldhuisen
Unraveling the mechanisms for heart failure patients' beliefs about compliance.
Heart & lung : the journal of critical care 2007;36(4):253-61.
2007: Folkert Asselbergs; Wiek H van Gilst
Angiotensin converting enzyme inhibition in cardiovascular risk populations: a practical approach to identify the patient who will benefit most.
Current opinion in cardiology 2007;22(4):267-72.
2007: Cheng Qian; René A Tio; Anton J M Roks; Kristien M Boddeus; Martin C Harmsen; Wiek H van Gilst; Regien G Schoemaker
A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2007;16(3):127-35.
2007: Y Xu; Robert H Henning; Johannes van der Want; Azuwerus van Buiten; Wiek H van Gilst; Hendrik Buikema
Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds.
Life sciences 2007;80(18):1678-85.
2007: Pim van der Harst; Gerrit van der Steege; Rudolf A de Boer; Adriaan A Voors; Alistair Hall; Marcel J Mulder; Wiek H van Gilst; Dirk J van Veldhuisen
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.
Journal of the American College of Cardiology 2007;49(13):1459-64.
2007: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.
Genomics 2007;89(3):362-9.
2007: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.
Journal of thrombosis and haemostasis : JTH 2007;5(2):313-20.
2007: Y Xu; Robert H Henning; Erik Lipsic; Azuwerus van Buiten; Wiek H van Gilst; Hendrik Buikema
Acetylcholine stimulated dilatation and stretch induced myogenic constriction in mesenteric artery of rats with chronic heart failure.
European journal of heart failure 2007;9(2):144-51.
2007: Annemarieke E Loot; Anton J M Roks; Dirk Westermann; Hans-Dieter Orzechowski; Carsten Tschöpe; Jan Wilschut; René A Tio; Wiek H van Gilst; Robert H Henning
Cardiac overexpression of human VEGF(165) by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(10):335-41.
2007: Christiane A Geluk; Riksta Dikkers; Jan A Kors; René A Tio; Riemer H J A Slart; Rozemarijn Vliegenthart; Hans L Hillege; Tineke P Willems; Paul E de Jong; Wiek H van Gilst; Matthijs Oudkerk; Felix Zijlstra
Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation study.
BMC cardiovascular disorders 2007;7():19.
2007: Christiane A Geluk; René A Tio; Jan G P Tijssen; RB van Dijk; W A Dijk; Hans L Hillege; Paul E de Jong; Wiek H van Gilst; Felix Zijlstra
Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(4):133-41.
2007: B Daan Westenbrink; Folkert W Visser; Adriaan A Voors; Tom D J Smilde; Erik Lipsic; gerjan navis; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
European heart journal 2007;28(2):166-71.
2007: Heidrun B Sturm; Wiek H van Gilst; Nic J G M Veeger; Flora M Haaijer-Ruskamp
Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
Pharmacoepidemiology and drug safety 2007;16(1):96-103.
2006: Erik Lipsic; Regien G Schoemaker; peter van der meer; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
Journal of the American College of Cardiology 2006;48(11):2161-7.
2006: Ruud M A van de Wal; Ron T Gansevoort; Pim van der Harst; Frans Boomsma; H W Thijs Plokker; Dirk J van Veldhuisen; Paul E de Jong; Wiek H van Gilst; Adriaan A Voors
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
Hypertension 2006;48(5):870-6.
2006: Jarir Atthobari; Auke H Brantsma; Ron T Gansevoort; Sipke T Visser; Folkert Asselbergs; Wiek H van Gilst; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(11):3106-14.
2006: Folkert Asselbergs; scott williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; gerjan navis; Douglas E Vaughan; Wiek H van Gilst; Jason Moore
The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Thrombosis and haemostasis 2006;96(4):471-7.
2006: Pim van der Harst; Folkert Asselbergs; Hendrik Buikema; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of C-reactive protein and cholesterol on responsiveness in vitro of the internal thoracic artery to angiotensin II in patients having coronary artery bypass grafting.
The American journal of cardiology 2006;98(6):751-3.
2006: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Statins in the treatment of chronic heart failure: a systematic review.
PLoS medicine 2006;3(8):e333.
2006: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Statins in the treatment of chronic heart failure: biological and clinical considerations.
Cardiovascular research 2006;71(3):443-54.
2006: Pim van der Harst; Adriaan A Voors; Meint Volbeda; Hendrik Buikema; Dirk J van Veldhuisen; Wiek H van Gilst
Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
The American journal of cardiology 2006;97(12):1697-701.
2006: Wiek H van Gilst; J Wayne Warnica; Richard Baillot; David Johnstone; Cristina-Dana Calciu; Pierre Block; Martin G Myers; Sidney Chocron; Jean-Lucien Rouleau
Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
American heart journal 2006;151(6):1240-6.
2006: Erik Lipsic; peter van der meer; Adriaan A Voors; B Daan Westenbrink; Ad F M van den Heuvel; Hetty C de Boer; Anton-Jan van Zonneveld; Regien G Schoemaker; Wiek H van Gilst; Felix Zijlstra; Dirk J van Veldhuisen
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(2):135-41.
2006: Folkert Asselbergs; Pim van der Harst; Wiek H van Gilst
Letter regarding article by Arnlov et al, "low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals".
Circulation 2006;113(10):e406; author reply e406-7.
2006: Jarir Atthobari; Folkert Asselbergs; Cornelis Boersma; Robin de Vries; Hans L Hillege; Wiek H van Gilst; Ron T Gansevoort; Paul E de Jong; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Clinical therapeutics 2006;28(3):432-44.
2006: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Frans Boomsma; Dirk J van Veldhuisen; Wiek H van Gilst
Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction.
European journal of heart failure 2006;8(2):122-30.
2006: Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
The current role of ACE-inhibitors for secondary prevention in cardiovascular disease; from pathogenesis to clinical practice.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(1):69-73.
2006: Pim van der Harst; Tom D J Smilde; Hendrik Buikema; Adriaan A Voors; gerjan navis; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular function and mild renal impairment in stable coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):379-84.
2006: Martje H L van der Wal; Tiny Jaarsma; Debra Moser; Nic J G M Veeger; Wiek H van Gilst; Dirk J van Veldhuisen
Compliance in heart failure patients: the importance of knowledge and beliefs.
European heart journal 2006;27(4):434-40.
2006: Ruud M A van de Wal; H W M Plokker; D J A Lok; F Boomsma; F A L van der Horst; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
International journal of cardiology 2006;106(3):367-72.
2006: Folkert Asselbergs; Jason Moore; Maarten P van den Berg; Eric B Rimm; Rudolf A de Boer; Robin P Dullaart; gerjan navis; Wiek H van Gilst
A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study.
BMC medical genetics 2006;7():39.
2006: Heidrun B Sturm; Flora M Haaijer-Ruskamp; Nic J G M Veeger; Corine P Baljé-Volkers; Karl Swedberg; Wiek H van Gilst
The relevance of comorbidities for heart failure treatment in primary care: A European survey.
European journal of heart failure 2006;8(1):31-7.
2005: Bart Westendorp; Regien G Schoemaker; Wiek H van Gilst; Dirk J van Veldhuisen; Hendrik Buikema
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
European journal of pharmacology 2005;527(1-3):141-9.
2005: Adriaan A Voors; Peter P van Geel; Hendrik Buikema; Margreeth Oosterga; Dirk J van Veldhuisen; Wiek H van Gilst
High angiotensin II responsiveness is associated with decreased endothelium-dependent relaxation in human arteries.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2005;6(3):145-50.
2005: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Dick De Zeeuw; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen
Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.
European journal of heart failure 2005;7(7):1085-94.
2005: Bart Westendorp; Regien G Schoemaker; Wiek H van Gilst; Hendrik Buikema
Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction.
Journal of cardiovascular pharmacology 2005;46(6):766-72.
2005: Folkert Asselbergs; Wiek H van Gilst
Urinary albumin excretion and carotid intima-media thickness.
Hypertension 2005;46(6):e20.
2005: Harvey D White; Philip E G Aylward; Zhen Huang; Anthony J Dalby; W Douglas Weaver; Ståle Barvik; José Antonio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H van Gilst; Faiez Zannad; john mcmurray; Robert M Califf; Marc A Pfeffer
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Pim van der Harst; Lodewijk J Wagenaar; Hendrik Buikema; Adriaan A Voors; H W M Plokker; Wim J Morshuis; A Jacob Six; Piet W Boonstra; Georg Nickenig; Sven Wassmann; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
The American journal of cardiology 2005;96(10):1361-4.
2005: Ruud M A van de Wal; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?
European heart journal 2005;26(22):2361-7.
2005: Adrian F Hernandez; Eric J Velazquez; Scott D Solomon; Rakhi Kilaru; Rafael Diaz; Christopher M O'Connor; George Ertl; Aldo P Maggioni; Jean-Lucien Rouleau; Wiek H van Gilst; Marc A Pfeffer; Robert M Califf
Left ventricular assessment in myocardial infarction: the VALIANT registry.
Archives of internal medicine 2005;165(18):2162-9.
2005: Ruud M A van de Wal; Folkert Asselbergs; H W M Plokker; Tom D J Smilde; Dirk Lok; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
High prevalence of microalbuminuria in chronic heart failure patients.
Journal of cardiac failure 2005;11(8):602-6.
2005: peter van der meer; Erik Lipsic; B Daan Westenbrink; Ruud M A van de Wal; Regien G Schoemaker; Edo Vellenga; Dirk J van Veldhuisen; Adriaan A Voors; Wiek H van Gilst
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
Circulation 2005;112(12):1743-7.
2005: Folkert Asselbergs; Lieuwe H Piers; Gillian A J Jessurun; Ad J van Boven; Nic J G M Veeger; Felix Zijlstra; Wiek H van Gilst; René A Tio
Determination of vessel size: a putative framework to assess clinical outcome.
International journal of cardiology 2005;103(2):135-9.
2005: Lodewijk J Wagenaar; Braim M Rahel; Ad J van Boven; Adriaan A Voors; Allard C van der Wal; H W M Plokker; Wiek H van Gilst
Pre-procedural ACE-activity does not predict symptomatic in-stent restenosis.
International journal of cardiology 2005;103(1):73-7.
2005: peter van der meer; Erik Lipsic; Robert H Henning; Kristien M Boddeus; Jolanda van der Velden; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
Journal of the American College of Cardiology 2005;46(1):125-33.
2005: Christiane A Geluk; Folkert Asselbergs; Hans L Hillege; Stephan J L Bakker; Paul E de Jong; Felix Zijlstra; Wiek H van Gilst
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
European heart journal 2005;26(13):1314-20.
2005: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Statins and autonomic function in chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(3):167-8.
2005: Erik Lipsic; Iwan C C van der Horst; Adriaan A Voors; peter van der meer; Maarten W N Nijsten; Wiek H van Gilst; Dirk J van Veldhuisen; Felix Zijlstra
Hemoglobin levels and 30-day mortality in patients after myocardial infarction.
International journal of cardiology 2005;100(2):289-92.
2005: Bas Langeveld; Wiek H van Gilst; Felix Zijlstra
A simple, inexpensive, rapid, and accurate preclinical model for in-stent restenosis.
Journal of the American College of Cardiology 2005;45(8):1310; author reply 1310-1.
2005: Adriaan A Voors; Pieter J de Kam; Maarten P van den Berg; Claudio Borghi; Judith S Hochman; Dirk J van Veldhuisen; Wiek H van Gilst
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(2):119-24.
2005: Tom D J Smilde; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Jan A Kors; Ron T Gansevoort; Wiek H van Gilst; Paul E de Jong; Dirk J van Veldhuisen
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
American journal of hypertension 2005;18(3):342-7.
2005: Folkert Asselbergs; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Andries J Smit; Wiek H van Gilst
Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria.
Stroke; a journal of cerebral circulation 2005;36(3):649-53.
2005: Folkert Asselbergs; Pim van der Harst; Gillian A J Jessurun; René A Tio; Wiek H van Gilst
Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins.
Vascular pharmacology 2005;42(3):125-40.
2005: Ruud M A van de Wal; Ben L van Brussel; Adriaan A Voors; Tom D J Smilde; Johannes C Kelder; Henry A Van Swieten; Wiek H van Gilst; Dirk Jan van Veldhuisen; H W M Plokker
Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery.
The Journal of thoracic and cardiovascular surgery 2005;129(2):330-5.
2005: Heidrun B Sturm; Wiek H van Gilst; Karl Swedberg; F D Richard Hobbs; Flora M Haaijer-Ruskamp
Heart failure guidelines and prescribing in primary care across Europe.
BMC health services research 2005;5():57.
2005: peter van der meer; Erik Lipsic; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin: from hematopoiesis to cardioprotection.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(1):7-8.
2005: Folkert Asselbergs; Maarten P van den Berg; Gilles F H Diercks; Wiek H van Gilst; Dirk J van Veldhuisen
C-reactive protein and microalbuminuria are associated with atrial fibrillation.
International journal of cardiology 2005;98(1):73-7.
2005: Bas Langeveld; Anton J M Roks; René A Tio; Adriaan A Voors; Felix Zijlstra; Wiek H van Gilst
Renin-angiotensin system intervention to prevent in-stent restenosis: an unclosed chapter.
Journal of cardiovascular pharmacology 2005;45(1):88-98.
2005: Bas Langeveld; Wiek H van Gilst; René A Tio; Felix Zijlstra; Anton J M Roks
Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.
Hypertension 2005;45(1):138-41.
2004: Pieter J de Kam; Adriaan A Voors; Francesco Fici; Dirk J van Veldhuisen; Wiek H van Gilst
The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(4):161-8.
2004: Anton J M Roks; Jeroen Nijholt; Azuwerus van Buiten; Wiek H van Gilst; Dick De Zeeuw; Robert H Henning
Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1-7) on angiotensin II.
Journal of hypertension 2004;22(12):2355-61.
2004: peter van der meer; Erik Lipsic; Robert H Henning; Rudolf A de Boer; Albert J H Suurmeijer; Dirk J van Veldhuisen; Wiek H van Gilst
Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.
European journal of heart failure 2004;6(7):853-9.
2004: Pim van der Harst; Meint Volbeda; Adriaan A Voors; Hendrik Buikema; Sven Wassmann; Michael Böhm; Georg Nickenig; Wiek H van Gilst
Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting.
Hypertension 2004;44(6):930-4.
2004: Folkert Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick De Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Circulation 2004;110(18):2809-16.
2004: Ruud M A van de Wal; Adriaan A Voors; H W M Plokker; Wiek H van Gilst; Dirk J van Veldhuisen
New pharmacological strategies in chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):491-501.
2004: Joost P van Melle; Hendrik Buikema; Maarten P van den Berg; Azuwerus van Buiten; Dirk J van Veldhuisen; Piet W Boonstra; Wiek H van Gilst
Sertraline causes strong coronary vasodilation: possible relevance for cardioprotection by selective serotonin reuptake inhibitors.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):441-7.
2004: Eric J Velazquez; Gary S Francis; Paul W Armstrong; Philip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek H van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; john mcmurray; Marc A Pfeffer; Robert M Califf
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Folkert Asselbergs; Hans L Hillege; Wiek H van Gilst
Framingham score and microalbuminuria: combined future targets for primary prevention?
Kidney international. Supplement 2004;(92):S111-4.
2004: Folkert Asselbergs; Stefan H J Monnink; Gillian A J Jessurun; Ad J van Boven; Nic J G M Veeger; Felix Zijlstra; Wiek H van Gilst; René A Tio
Assessing the prognostic value of coronary endothelial function in patients referred for a first coronary angiogram.
The American journal of cardiology 2004;94(8):1063-7.
2004: Erik Lipsic; peter van der meer; Robert H Henning; Albert J H Suurmeijer; Kristien M Boddeus; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.
Journal of cardiovascular pharmacology 2004;44(4):473-9.
2004: Rudolf A de Boer; Saraswati Pokharel; Markus Flesch; Derk A van Kampen; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen; Yigal M Pinto
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
Journal of molecular medicine (Berlin, Germany) 2004;82(10):678-87.
2004: Adriaan A Voors; Peter P van Geel; Margreeth Oosterga; Hendrik Buikema; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(3):130-4.
2004: Bas Langeveld; Anton J M Roks; René A Tio; Ad J van Boven; Johannes van der Want; Robert H Henning; Heleen M M van Beusekom; Willem J van der Giessen; Felix Zijlstra; Wiek H van Gilst
Rat abdominal aorta stenting: a new and reliable small animal model for in-stent restenosis.
Journal of vascular research 2004;41(5):377-86.
2004: Stefan H J Monnink; René A Tio; Ad J van Boven; Wiek H van Gilst; Dirk J van Veldhuisen
The role of coronary endothelial function testing in patients suspected for angina pectoris.
International journal of cardiology 2004;96(2):123-9.
2004: Pim van der Harst; Wiek H van Gilst; Felix Zijlstra
Aggressive lipid-lowering therapy and regression of coronary atheroma.
JAMA : the journal of the American Medical Association 2004;292(1):39; author reply 39-40.
2004: peter van der meer; Adriaan A Voors; Erik Lipsic; Tom D J Smilde; Wiek H van Gilst; Dirk J van Veldhuisen
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
Journal of the American College of Cardiology 2004;44(1):63-7.
2004: Annemarieke E Loot; Robert H Henning; Leo E Deelman; René A Tio; Pieter Schoen; Jan Wilschut; Wiek H van Gilst; Anton J M Roks
Semliki Forest virus is an efficient and selective vector for gene delivery in infarcted rat heart.
Journal of molecular and cellular cardiology 2004;37(1):137-42.
2004: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Dick De Zeeuw; Dirk J van Veldhuisen; Wiek H van Gilst
Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(1):27-32.
2004: peter van der meer; Adriaan A Voors; Erik Lipsic; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin in cardiovascular diseases.
European heart journal 2004;25(4):285-91.
2004: Folkert Asselbergs; Rudolf A de Boer; Gilles F H Diercks; Bas Langeveld; René A Tio; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria?
International journal of cardiology 2004;93(2-3):211-5.
2004: Folkert Asselbergs; Stefan H J Monnink; Nic J G M Veeger; Ad J van Boven; Paul L van Haelst; Gillian A J Jessurun; Wiek H van Gilst; René A Tio
Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris.
Clinical science (London, England : 1979) 2004;106(2):115-20.
2003: Martin H de Borst; gerjan navis; Rudolf A de Boer; Sippie Huitema; Lotte M Vis; Wiek H van Gilst; Harry van Goor
Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats.
Laboratory investigation; a journal of technical methods and pathology 2003;83(12):1761-70.
2003: Lodewijk J Wagenaar; Ad J van Boven; Allard C van der Wal; Giovanni Amoroso; René A Tio; Chris M van der Loos; Anton E Becker; Wiek H van Gilst
Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries.
Cardiovascular research 2003;59(4):980-7.
2003: Paul L van Haelst; J W Cohen Tervaert; Peter P van Geel; Nic J G M Veeger; O Gurné; Rijk O B Gans; Wiek H van Gilst
Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2003;26(4):387-91.
2003: peter van der meer; Wiek H van Gilst; Dirk J van Veldhuisen
Anemia and congestive heart failure.
Circulation 2003;108(6):e41-2; author reply e41-2.
2003: Simone Gschwend; Robert H Henning; Yigal M Pinto; Dick De Zeeuw; Wiek H van Gilst; Hendrik Buikema
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
British journal of pharmacology 2003;139(7):1317-25.
2003: Stefan H J Monnink; René A Tio; Nic J G M Veeger; Giovanni Amoroso; Ad J van Boven; Wiek H van Gilst
Exercise-induced ischemia after successful percutaneous coronary intervention is related to distal coronary endothelial dysfunction.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2003;51(4):221-6.
2003: Lisa G Pont; Miriam C J M Sturkenboom; Wiek H van Gilst; Petra Denig; Flora M Haaijer-Ruskamp
Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000.
Pharmacoepidemiology and drug safety 2003;12(4):327-34.
2003: Folkert Asselbergs; Ad J van Boven; Erik M Stuveling; Gilles F H Diercks; Hans L Hillege; Jan A Kors; Paul E de Jong; Wiek H van Gilst
Relation of electrocardiographic abnormalities to levels of serum C-reactive protein.
The American journal of cardiology 2003;91(11):1358-60.
2003: Peter P van Geel; Hendrik Buikema; Jean-Lucien Rouleau; Wiek H van Gilst
Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.
The Canadian journal of cardiology 2003;19(6):701-4.
2003: Han J G H Mulder; Peter P van Geel; Martin J Schalij; Wiek H van Gilst; Aeilko H Zwinderman; A V G Bruschke
DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial.
Heart (British Cardiac Society) 2003;89(5):557-8.
2003: Lisa G Pont; Wiek H van Gilst; Dirk J A Lok; Hans J A Kragten; Flora M Haaijer-Ruskamp
The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice.
European journal of heart failure 2003;5(2):187-93.
2003: Simone Gschwend; Hendrik Buikema; Robert H Henning; Yigal M Pinto; Dick De Zeeuw; Wiek H van Gilst
Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failure.
European journal of heart failure 2003;5(2):147-54.
2003: Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen; gerjan navis; Diederick Grobbee; Pieter A de Graeff; Dick De Zeeuw
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.
European heart journal 2003;24(5):412-20.
2003: Rudolf A de Boer; Yigal M Pinto; Albert J H Suurmeijer; Saraswati Pokharel; Egbert Scholtens; Michael Humler; Juan M Saavedra; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen
Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction.
Cardiovascular research 2003;57(2):434-42.
2003: Adriaan A Voors; Margreeth Oosterga; Hendrik Buikema; Massimo Mariani; Jan G Grandjean; Wiek H van Gilst
Differences between angiotensin-converting enzyme inhibition and angiotensin II-AT1 antagonism on angiotensin-mediated responses in human internal mammary arteries.
Journal of cardiovascular pharmacology 2003;41(2):178-84.
2003: Dirk J van Veldhuisen; Wiek H van Gilst
The pharmacological management of heart failure: too many treatments?
European journal of heart failure 2003;5(1):5-8.
2002: Lodewijk J Wagenaar; Adriaan A Voors; Hendrik Buikema; Wiek H van Gilst
Angiotensin receptors in the cardiovascular system.
The Canadian journal of cardiology 2002;18(12):1331-9.
2002: Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Jan A Kors; Harry J G M Crijns; Diederick Grobbee; Paul E de Jong; Wiek H van Gilst
Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes.
Journal of the American College of Cardiology 2002;40(8):1401.
2002: Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick De Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick Grobbee; Paul E de Jong
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Circulation 2002;106(14):1777-82.
2002: Rudolf A de Boer; Robert H Henning; René A Tio; Yigal M Pinto; R M H J Brouwer; R J Ploeg; M Böhm; Wiek H van Gilst; D J Van Veldhuisen
Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy.
Heart (British Cardiac Society) 2002;88(4):412-4.
2002: Saraswati Pokharel; Saman Rasoul; Anton J M Roks; Rick E W van Leeuwen; Marja J A van Luyn; Leo E Deelman; Jos F M Smits; Oscar Carretero; Wiek H van Gilst; Yigal M Pinto
N-acetyl-Ser-Asp-Lys-Pro inhibits phosphorylation of Smad2 in cardiac fibroblasts.
Hypertension 2002;40(2):155-61.
2002: Lodewijk J Wagenaar; Adriaan A Voors; Hendrik Buikema; Azuwerus van Buiten; Rob H Lübeck; Piet W Boonstra; Dirk J van Veldhuisen; Wiek H van Gilst
Functional antagonism of different angiotensin II type I receptor blockers in human arteries.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(4):311-6.
2002: Simone Gschwend; Sara-Joan Pinto-Sietsma; Hendrik Buikema; Yigal M Pinto; Wiek H van Gilst; Angela Schulz; Dick De Zeeuw; Reinhold Kreutz
Impaired coronary endothelial function in a rat model of spontaneous albuminuria.
Kidney international 2002;62(1):181-91.
2002: Gilles F H Diercks; Erik S G Stroes; Ad J van Boven; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Andries J Smit; Rijk O B Gans; Harry J G M Crijns; ton rabelink; Wiek H van Gilst
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects.
Atherosclerosis 2002;163(1):121-6.
2002: Pieter J de Kam; Adriaan A Voors; Jan Brouwer; Martin St John Sutton; Wiek H van Gilst
Approaches to statistical analysis of repeated echocardiographic measurements after myocardial infarction and its relation to heart failure: Application of a random-effects model.
European journal of heart failure 2002;4(3):277-82.
2002: Bianca J J M Brundel; Jannie Ausma; Isabelle C Van Gelder; Johannes van der Want; Wiek H van Gilst; Harry J G M Crijns; Robert H Henning
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.
Cardiovascular research 2002;54(2):380-9.
2002: Gilles F H Diercks; Ad J van Boven; J L Hillege; Paul E de Jong; J L Rouleau; Wiek H van Gilst
The importance of microalbuminuria as a cardiovascular risk indicator: A review.
The Canadian journal of cardiology 2002;18(5):525-35.
2002: Anton J M Roks; R H Henning; Ad J van Boven; René A Tio; Wiek H van Gilst
Rat abdominal aortic stenting: a simple model displaying in-stent restenosis.
The American journal of cardiology 2002;89(9):1149-50.
2002: Gilles F H Diercks; Erik S G Stroes; Ad J van Boven; Arie M Van Roon; Hans L Hillege; Paul E de Jong; Andries J Smit; Rijk O B Gans; Harry J G M Crijns; ton rabelink; Wiek H van Gilst
Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects.
Diabetes care 2002;25(5):936-7.
2002: Annemarieke E Loot; Anton J M Roks; Robert H Henning; René A Tio; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst
Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats.
Circulation 2002;105(13):1548-50.
2002: Pieter J de Kam; Gian Luigi Nicolosi; Adriaan A Voors; Maarten P van den Berg; Jan Brouwer; D J van Veldhuisen; S Barlera; A P Maggioni; Pantaleo Giannuzzi; Pier Luigi Temporelli; R Latini; Wiek H van Gilst
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data.
European heart journal 2002;23(7):536-42.
2002: Rudolf A de Boer; Peter P van Geel; Yigal M Pinto; Albert J H Suurmeijer; Harry J G M Crijns; Wiek H van Gilst; Dirk J van Veldhuisen
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
Journal of cardiovascular pharmacology 2002;39(4):610-9.
2002: Victor J Dzau; Kenneth Bernstein; David S Celermajer; Jerome Cohen; Björn Dahlöf; John Deanfield; Javier Diez; Helmut Drexler; Roberto Ferrari; Wiek H van Gilst; Lennart Hansson; Burkhard Hornig; Ahsan Husain; Colin Johnston; Harold Lazar; Eva Lonn; Thomas Lüscher; John Mancini; Albert Mimran; Carl Pepine; Ton Rabelink; Willem Remme; Luis M Ruilope; Marcel Ruzicka; Heribert Schunkert; Karl Swedberg; Thomas Unger; Douglas Vaughan; Michael Weber
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(2):149-60.
2002: René A Tio; Stefan H J Monnink; Giovanni Amoroso; Gillian A J Jessurun; Nic J G M Veeger; Corine P Volkers; Raymond W M Hautvast; Eng S Tan; Wiek H van Gilst; Ad J van Boven
Safety evaluation of routine intracoronary acetylcholine infusion in patients undergoing a first diagnostic coronary angiogram.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2002;50(2):133-9.
2002: René A Tio; Jan G Grandjean; Albert J H Suurmeijer; Wiek H van Gilst; Dirk J van Veldhuisen; Ad J van Boven
Thoracoscopic monitoring for pericardial application of local drug or gene therapy.
International journal of cardiology 2002;82(2):117-21.
2002: Hans Hillege; Wiek H van Gilst; Dick De Zeeuw; Dirk Jan van Veldhuisen
Renal function as a predictor of prognosis in chronic heart failure.
Heart failure monitor 2002;2(3):78-84.
2002: Anton J M Roks; Robert H Henning; Hendrik Buikema; Yigal M Pinto; M J J Kraak; René A Tio; D de Zeeuw; Hidde J Haisma; Jan Wilschut; Wiek H van Gilst
Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta.
Gene therapy 2002;9(2):95-101.
2002: Stefan H J Monnink; Paul L van Haelst; Ad J van Boven; Erik S G Stroes; René A Tio; Thijs W M Plokker; Andries J Smit; Nic J G M Veeger; Harry J G M Crijns; Wiek H van Gilst
Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2002;50(1):19-24.
2001: Victor J Dzau; K Bernstein; David S Celermajer; J Cohen; B Dahlöf; John Deanfield; J Diez; Helmut Drexler; R Ferrari; Wiek H van Gilst; L Hansson; B Hornig; A Husain; C Johnston; H Lazar; Eva Lonn; T Lüscher; J Mancini; Albert Mimran; Carl Pepine; T Rabelink; W Remme; Luis M Ruilope; M Ruzicka; Heribert Schunkert; K Swedberg; T Unger; D Vaughan; M Weber
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.
The American journal of cardiology 2001;88(9A):1L-20L.
2001: Sigrid Hoffmann; T Krause; Peter P van Geel; Roland Willenbrock; Ines Pagel; Yigal M Pinto; Hendrik Buikema; Wiek H van Gilst; Carsten Lindschau; Martin Paul; T Inagami; Detlev Ganten; H Urata
Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
Journal of molecular medicine (Berlin, Germany) 2001;79(10):601-8.
2001: Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Jan A Kors; Wilbert M T Janssen; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst
Relation between albumin in the urine and electrocardiographic markers of myocardial ischemia in patients without diabetes mellitus.
The American journal of cardiology 2001;88(7):771-4.
2001: Bianca J J M Brundel; Isabelle C Van Gelder; Anton E Tuinenburg; Mirian Wietses; Dirk J van Veldhuisen; Wiek H van Gilst; Harry J G M Crijns; Robert H Henning
Endothelin system in human persistent and paroxysmal atrial fibrillation.
Journal of cardiovascular electrophysiology 2001;12(7):737-42.
2001: Hans L Hillege; Wilbert M T Janssen; AA Bak; Gilles F H Diercks; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst; Dick De Zeeuw; Paul E de Jong
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.
Journal of internal medicine 2001;249(6):519-26.
2001: Peter P van Geel; Yigal M Pinto; A H Zwinderman; Robert H Henning; Ad J van Boven; J W Jukema; A V G Bruschke; J J Kastelein; Wiek H van Gilst
Increased risk for ischaemic events is related to combined RAS polymorphism.
Heart (British Cardiac Society) 2001;85(4):458-62.
2001: Bianca J J M Brundel; Isabelle C Van Gelder; Robert H Henning; Anton E Tuinenburg; Mirian Wietses; Jan G Grandjean; Arthur A M Wilde; Wiek H van Gilst; Harry J G M Crijns
Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.
Journal of the American College of Cardiology 2001;37(3):926-32.
2001: Rudolf A de Boer; R H Henning; Albert J H Suurmeijer; Yigal M Pinto; E Olthof; J H Kirkels; Wiek H van Gilst; Harry J G M Crijns; Dirk J van Veldhuisen
Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease.
International journal of cardiology 2001;78(1):5-12.
2001: Margreeth Oosterga; Adriaan A Voors; Yigal M Pinto; Hendrik Buikema; Jan G Grandjean; J Herre Kingma; Harry J G M Crijns; Wiek H van Gilst
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
The American journal of cardiology 2001;87(5):542-6.
2001: Bianca J J M Brundel; Isabelle C Van Gelder; Robert H Henning; Robert G Tieleman; Anton E Tuinenburg; Mirian Wietses; Jan G Grandjean; Wiek H van Gilst; Harry J G M Crijns
Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation.
Circulation 2001;103(5):684-90.
2001: Ad F M van den Heuvel; Peter H J M Dunselman; T Kingma; P Verhorst; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen
Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
Journal of the American College of Cardiology 2001;37(2):470-4.
2000: Pieter J de Kam; Adriaan A Voors; Maarten P van den Berg; Dirk J van Veldhuisen; Jan Brouwer; Harry J G M Crijns; C Borghi; E Ambrosioni; Judith S Hochman; T H LeJemtel; J Herre Kingma; M S Sutton; Wiek H van Gilst
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators.
Journal of the American College of Cardiology 2000;36(7):2047-53.
2000: Gilles F H Diercks; Ad J van Boven; Hans L Hillege; Wilbert M T Janssen; Jan A Kors; Paul E de Jong; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study.
European heart journal 2000;21(23):1922-7.
2000: Yigal M Pinto; M Bader; J B Pesquero; Carsten Tschöpe; Egbert Scholtens; Wiek H van Gilst; Hendrik Buikema
Increased kallikrein expression protects against cardiac ischemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(13):1861-3.
2000: Gilles F H Diercks; Wilbert M T Janssen; Ad J van Boven; AA Bak; Paul E de Jong; Harry J G M Crijns; Wiek H van Gilst
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).
The American journal of cardiology 2000;86(6):635-8.
2000: Hendrik Buikema; Stefan H J Monnink; René A Tio; Harry J G M Crijns; Dick De Zeeuw; Wiek H van Gilst
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
British journal of pharmacology 2000;130(8):1999-2007.
2000: AC Teisman; Hendrik Buikema; Dirk J van Veldhuisen; Dick De Zeeuw; Wiek H van Gilst
Direct vasodilating effects of the new dopaminergic agonist Z1046 in human arteries.
Journal of cardiovascular pharmacology 2000;35(4):581-5.
2000: AC Teisman; Dirk J van Veldhuisen; Frans Boomsma; Pieter J de Kam; Geert Tjeerdsma; Yigal M Pinto; Dick De Zeeuw; Wiek H van Gilst
Chronic beta-blocker treatment in patients with advanced heart failure. Effects on neurohormones.
International journal of cardiology 2000;73(1):7-12; discussion 13-4.
2000: Peter P van Geel; Yigal M Pinto; Adriaan A Voors; Hendrik Buikema; Margreeth Oosterga; Harry J G M Crijns; Wiek H van Gilst
Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries.
Hypertension 2000;35(3):717-21.
2000: Rutger L Anthonio; Dirk J van Veldhuisen; A Breekland; Harry J G M Crijns; Wiek H van Gilst
Beta-blocker titration failure is independent of severity of heart failure.
The American journal of cardiology 2000;85(4):509-12, A11.
2000: Margreeth Oosterga; Adriaan A Voors; Hendrik Buikema; Yigal M Pinto; H E Haber; Tjark Ebels; W J Morshuis; J Herre Kingma; Harry J G M Crijns; Wiek H van Gilst
Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2000;14(1):55-60.
2000: Rutger L Anthonio; O E Brodde; Dirk J van Veldhuisen; Egbert Scholtens; Harry J G M Crijns; Wiek H van Gilst
Beta-adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of beta1-adrenoceptor density.
International journal of cardiology 2000;72(2):137-41.
2000: AC Teisman; Ben H C Westerink; Dirk J van Veldhuisen; Egbert Scholtens; Dick De Zeeuw; Wiek H van Gilst
Direct interaction between the sympathetic and renin-angiotensin system in myocardial tissue: a microdialysis study in anaesthetised rats.
Journal of the autonomic nervous system 2000;78(2-3):117-21.
2000: Ad F M van den Heuvel; Dirk J van Veldhuisen; Ernst E van der Wall; Paul K Blanksma; Hans-Marc J Siebelink; Willem Vaalburg; Wiek H van Gilst; Harry J G M Crijns
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
Journal of the American College of Cardiology 2000;35(1):19-28.
1999: René A Tio; Stefan H J Monnink; Gillian A J Jessurun; J O J Peels; Ad J van Boven; Wiek H van Gilst; H G Crijns
A comparison of the cold pressor test and the diving test or coronary and systemic hemodynamics in patients with and without coronary artery disease.
International journal of cardiology 1999;71(1):7-15.
1999: Yigal M Pinto; Peter P van Geel; H Alkfaji; Dirk J van Veldhuisen; Wiek H van Gilst
Dosing of ACE inhibitors in left ventricular dysfunction: does current clinical dosing provide optimal benefit?
Journal of cardiovascular pharmacology 1999;34 Suppl 1():S13-7.
1999: Anton J M Roks; Peter P van Geel; Yigal M Pinto; Hendrik Buikema; Robert H Henning; Dick De Zeeuw; Wiek H van Gilst
Angiotensin-(1-7) is a modulator of the human renin-angiotensin system.
Hypertension 1999;34(2):296-301.
1999: Anton E Tuinenburg; Bianca J J M Brundel; Isabelle C Van Gelder; Robert H Henning; Maarten P van den Berg; C Driessen; Jan G Grandjean; Wiek H van Gilst; Harry J G M Crijns
Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation.
Journal of cardiovascular electrophysiology 1999;10(6):827-35.
1999: Bianca J J M Brundel; Isabelle C Van Gelder; Robert H Henning; Anton E Tuinenburg; Leo E Deelman; Robert G Tieleman; Jan G Grandjean; Wiek H van Gilst; Harry J G M Crijns
Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation.
Cardiovascular research 1999;42(2):443-54.
1999: Rutger L Anthonio; Jan Brouwer; P Lechat; Jaap Haaksma; L van der Ven; Dirk J van Veldhuisen; Harry J G M Crijns; Wiek H van Gilst
Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS]).
The American journal of cardiology 1999;83(8):1286-9, A10.
1999: Isabelle C Van Gelder; Bianca J J M Brundel; Robert H Henning; Anton E Tuinenburg; Robert G Tieleman; Leo E Deelman; Jan G Grandjean; Pieter J de Kam; Wiek H van Gilst; Harry J G M Crijns
Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation.
Journal of cardiovascular electrophysiology 1999;10(4):552-60.
1998: AC Teisman; Yigal M Pinto; Hendrik Buikema; Markus Flesch; Michael Böhm; Martin Paul; Wiek H van Gilst
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Journal of hypertension 1998;16(12 Pt 1):1759-65.
1998: Raymond W M Hautvast; Mike J L DeJongste; Michiel J Staal; Wiek H van Gilst; KI Lie
Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study.
American heart journal 1998;136(6):1114-20.
1998: Adriaan A Voors; Yigal M Pinto; Hendrik Buikema; H Urata; Margreeth Oosterga; G Rooks; Jan G Grandjean; D Ganten; Wiek H van Gilst
Dual pathway for angiotensin II formation in human internal mammary arteries.
British journal of pharmacology 1998;125(5):1028-32.
1998: Michael Böhm; S Ettelbrück; Markus Flesch; Wiek H van Gilst; Andreas Knorr; Christoph Maack; Yigal M Pinto; Martin Paul; AC Teisman; Oliver Zolk
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
Cardiovascular research 1998;40(1):146-55.
1998: E J Göbel; Wiek H van Gilst; Pieter J de Kam; M G ter Napel; G P Molhoek; KI Lie
Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris.
European heart journal 1998;19(8):1208-13.
1998: Peter P van Geel; Yigal M Pinto; Hendrik Buikema; Wiek H van Gilst
Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease?
European heart journal 1998;19 Suppl G():G13-7.
1998: Margreeth Oosterga; Rutger L Anthonio; Pieter J de Kam; J Herre Kingma; Harry J G M Crijns; Wiek H van Gilst
Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction.
The American journal of cardiology 1998;81(10):1178-81.
1998: Oliver Zolk; Markus Flesch; Petra Schnabel; AC Teisman; Yigal M Pinto; Wiek H van Gilst; Martin Paul; Michael Böhm
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
British journal of pharmacology 1998;123(3):405-12.
1998: Rutger L Anthonio; Dirk J van Veldhuisen; Wiek H van Gilst
Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both?
Journal of cardiovascular pharmacology 1998;32 Suppl 1():S1-8.
1998: Dirk J van Veldhuisen; Wiek H van Gilst; G S Francis
Current insights and new treatment options in heart failure.
Journal of cardiovascular pharmacology 1998;32 Suppl 1():v-vi.
1998: M Stula; Yigal M Pinto; Simone Gschwend; AC Teisman; Wiek H van Gilst; Michael Böhm; Rainer Dietz; Martin Paul
Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S403-5.
1997: Thomas I F H Cremers; AC Teisman; Wiek H van Gilst; Ben H C Westerink
Use of microdialysis for monitoring sympathetic and parasympathetic innervation of heart in conscious rats.
The American journal of physiology 1997;273(6 Pt 2):H2850-6.
1997: RJ de Vries; Rutger L Anthonio; Dirk J van Veldhuisen; Egbert Scholtens; Hendrik Buikema; Wiek H van Gilst
Effects of amlodipine on endothelial function in rats with chronic heart failure after experimental myocardial infarction.
Journal of cardiovascular pharmacology 1997;30(5):683-9.
1997: Rutger L Anthonio; Dirk J van Veldhuisen; Egbert Scholtens; C van Bekkum; E de Boer; Wiek H van Gilst
Myocardial infarction with aortic banding. A combined rat model of heart failure.
Japanese heart journal 1997;38(5):697-708.
1997: Anton J M Roks; Yigal M Pinto; Martin Paul; F Pries; M Stula; T Eschenhagen; Hans-Dieter Orzechowski; S Gschwendt; Jan Wilschut; Wiek H van Gilst
Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus.
Cardiovascular research 1997;35(3):498-504.
1997: AC Teisman; Dirk J van Veldhuisen; Egbert Scholtens; W Maselbas; Wiek H van Gilst
Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats.
Journal of cardiac failure 1997;3(3):199-205.
1997: S A van den Broek; Pieter A de Graeff; Dirk J van Veldhuisen; Wiek H van Gilst; Hans L Hillege; H Wesseling; K I Lie
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
Journal of cardiac failure 1997;3(3):165-71.
1997: Ad F M van den Heuvel; Wiek H van Gilst; Dirk J van Veldhuisen; RJ de Vries; Peter H J M Dunselman; J Herre Kingma
Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The Captopril and Thrombolysis Study (CATS) Investigators.
Journal of the American College of Cardiology 1997;30(2):400-5.
1997: Margreeth Oosterga; Adriaan A Voors; Pieter J de Kam; H Schunkert; Yigal M Pinto; J Herre Kingma; Wiek H van Gilst
Plasma angiotensin-converting enzyme activity and left ventricular dilation after myocardial infarction.
Circulation 1997;95(12):2607-9.
1997: Adriaan A Voors; Margreeth Oosterga; Hendrik Buikema; Johan F May; Jan G Grandjean; Azuwerus van Buiten; Wiek H van Gilst
Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery.
Cardiovascular research 1997;34(3):568-74.
1997: Hendrik Buikema; Dirk J van Veldhuisen; H Hegeman; Wiek H van Gilst
Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: effects of ibopamine and captopril.
Journal of cardiac failure 1997;3(2):125-32.
1997: Hendrik Buikema; Yigal M Pinto; Peter P van Geel; G Rooks; CD De Langen; Pieter A de Graeff; Wiek H van Gilst
Differential inhibition of plasma versus tissue ACE by utibapril: biochemical and functional evidence for inhibition of vascular ACE activity.
Journal of cardiovascular pharmacology 1997;29(5):684-91.
1997: Yigal M Pinto; Hendrik Buikema; Wiek H van Gilst; Egbert Scholtens; Peter P van Geel; Pieter A de Graeff; J Wagner; Martin Paul
Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats.
Journal of molecular medicine (Berlin, Germany) 1997;75(5):371-7.
1997: Anton J M Roks; Hendrik Buikema; Yigal M Pinto; Wiek H van Gilst
The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
Heart and vessels 1997;Suppl 12():119-24.
1997: Robert G Tieleman; A T Marcel Gosselink; Harry J G M Crijns; Isabelle C Van Gelder; Maarten P van den Berg; Pieter J de Kam; Wiek H van Gilst; KI Lie
Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone.
The American journal of cardiology 1997;79(1):53-7.
1996: Hendrik Buikema; Yigal M Pinto; G Rooks; Jan G Grandjean; Heribert Schunkert; Wiek H van Gilst
The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries.
European heart journal 1996;17(5):787-94.
1996: A C Wiesfeld; Harry J G M Crijns; S A Van den Broek; M L Landsman; H L Hillege; Wiek H van Gilst; K I Lie
Angiographic left ventricular wall motion score to predict arrhythmia recurrence in patients with sustained ventricular tachycardia or fibrillation.
Coronary artery disease 1996;7(3):225-30.
1996: RJ de Vries; Peter H J M Dunselman; U G Chin Kon Sung; Dirk J van Veldhuisen; H M Corbeij; Wiek H van Gilst; K I Lie
Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.
Heart (British Cardiac Society) 1996;75(2):159-64.
1996: Yigal M Pinto; Hendrik Buikema; Wiek H van Gilst; K I Lie
Activated tissue renin-angiotensin systems add to the progression of heart failure.
Basic research in cardiology 1996;91 Suppl 2():85-90.
1996: E W van den Toren; Dirk J van Veldhuisen; A van Bruggen; S A van den Broek; Wiek H van Gilst; K I Lie
Acute hemodynamic and long-term clinical effects of isradipine in patients with coronary artery disease and chronic heart failure. A double-blind, placebo-controlled study.
International journal of cardiology 1996;53(1):37-43.
1995: E J Göbel; Raymond W M Hautvast; Wiek H van Gilst; J N Spanjaard; H L Hillege; Mike J L DeJongste; G P Molhoek; K I Lie
Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris.
Lancet 1995;346(8991-8992):1653-7.
1995: Adriaan A Voors; J Herre Kingma; Wiek H van Gilst
Drug differences between ACE inhibitors in experimental settings and clinical practice.
Journal of cardiovascular risk 1995;2(5):413-22.
1995: Dirk J van Veldhuisen; O E Brodde; Wiek H van Gilst; C Schulze; H Hegeman; Rutger L Anthonio; Egbert Scholtens; Pieter A de Graeff; H Wesseling; K I Lie
Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
Cardiovascular research 1995;30(3):386-93.
1995: Yigal M Pinto; Wiek H van Gilst; J Herre Kingma; Heribert Schunkert
Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators.
Journal of the American College of Cardiology 1995;25(7):1622-6.
1995: Yigal M Pinto; Hendrik Buikema; Wiek H van Gilst
Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1995;17(3):441-68.
1995: Ad J van Boven; H P de Haan; A E Saleh; Wiek H van Gilst; Johan F May; K I Lie
Hypertension and left ventricular hypertrophy in black people.
Journal of human hypertension 1995;9(3):205-6.
1995: S A van den Broek; Pieter A de Graeff; Andries J Smit; A R Girbes; Wiek H van Gilst; H Hillege; Dirk J van Veldhuisen; H Wesseling; K I Lie
Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
Journal of cardiovascular pharmacology 1995;25(1):105-12.
1994: Jan van der Meer; H L Hillege; Wiek H van Gilst; A Brutel de la Rivière; Peter H J M Dunselman; Vaclav Fidler; G J Kootstra; B J Mulder; M Pfisterer; K I Lie
A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
Circulation 1994;90(5):2367-74.
1994: Jan van der Meer; A Brutel de la Rivière; Wiek H van Gilst; H L Hillege; M Pfisterer; G J Kootstra; Peter H J M Dunselman; B J Mulder; K I Lie
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
Journal of the American College of Cardiology 1994;24(5):1181-8.
1994: T J Tobé; CD De Langen; Harry J G M Crijns; A C Wiesfeld; Wiek H van Gilst; K G Faber; K I Lie; H Wesseling
Late potentials, QTc prolongation, and prediction of arrhythmic events after myocardial infarction.
International journal of cardiology 1994;46(2):121-8.
1994: Wiek H van Gilst; Dirk J van Veldhuisen; H Hegeman; Hendrik Buikema; Egbert Scholtens; Pieter A de Graeff; K I Lie
Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril.
Journal of cardiovascular pharmacology 1994;24(1):171-4.
1994: E Wout van den Toren; RJ de Vries; M C Portegies; Paul K Blanksma; Wiek H van Gilst; H J Hillege; Dirk J van Veldhuisen; K I Lie
Effect of isradipine and nifedipine on diastolic function in patients with left ventricular dysfunction due to coronary artery disease: a randomized, double-blind, nuclear, stethoscope study.
Journal of cardiovascular pharmacology 1994;23(6):952-8.
1994: Dirk J van Veldhuisen; Wiek H van Gilst; B J de Smet; Pieter A de Graeff; Egbert Scholtens; Hendrik Buikema; A R Girbes; H Wesseling; K I Lie
Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1994;8(2):245-50.
1994: J van Wijngaarden; Andries J Smit; Pieter A de Graeff; Wiek H van Gilst; S A van der Broek; Dirk J van Veldhuisen; K I Lie; H Wesseling
Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
Journal of cardiovascular pharmacology 1994;23(2):240-5.
1993: Hendrik Buikema; Wiek H van Gilst; Dirk J van Veldhuisen; B J de Smet; Egbert Scholtens; K I Lie; H Wesseling
Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
Cardiovascular research 1993;27(12):2118-24.
1993: Yigal M Pinto; B G de Smet; Wiek H van Gilst; Egbert Scholtens; Stefan H J Monnink; Pieter A de Graeff; H Wesseling
Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology.
Cardiovascular research 1993;27(11):1933-8.
1993: T J Tobé; CD De Langen; Harry J G M Crijns; A C Wiesfeld; Wiek H van Gilst; K G Faber; K I Lie; H Wesseling
Effects of streptokinase during acute myocardial infarction on the signal-averaged electrocardiogram and on the frequency of late arrhythmias.
The American journal of cardiology 1993;72(9):647-51.
1993: R B van Dijk; Paul K Blanksma; Wiek H van Gilst; K I Lie
Influence of intravenous diltiazem on left ventricular function in patients with severe coronary artery disease at rest and during pacing, monitored by computer-processed nuclear probe and tip-manometer data.
Journal of cardiovascular pharmacology 1993;22(2):215-20.
1993: Jan van der Meer; H L Hillege; G J Kootstra; C A Ascoop; B J Mulder; M Pfisterer; Wiek H van Gilst; K I Lie
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
Lancet 1993;342(8866):257-64.
1993: S A van den Broek; Dirk J van Veldhuisen; Pieter A de Graeff; Harry J G M Crijns; Wiek H van Gilst; H Hillege; K I Lie
Mode of death in patients with congestive heart failure: comparison between possible candidates for heart transplantation and patients with less advanced disease.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1993;12(3):367-71.
1993: Dirk J van Veldhuisen; A R Girbes; S A van den Broek; Pieter A de Graeff; Wiek H van Gilst; K I Lie
Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure.
The American journal of cardiology 1993;71(11):992-4.
1992: Hendrik Buikema; Jan G Grandjean; S van den Broek; Wiek H van Gilst; K I Lie; H Wesseling
Differences in vasomotor control between human gastroepiploic and left internal mammary artery.
Circulation 1992;86(5 Suppl):II205-9.
1992: T J Tobé; CD De Langen; P H Mook; René A Tio; Klaas J Bel; Pieter A de Graeff; Wiek H van Gilst; H Wesseling
Late potentials in a porcine model of anterior wall myocardial infarction and their relation to inducible ventricular tachycardia.
Pacing and clinical electrophysiology : PACE 1992;15(11 Pt 1):1760-71.
1992: A C Wiesfeld; Harry J G M Crijns; Dirk J van Veldhuisen; Wiek H van Gilst; K I Lie
Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.
Clinical cardiology 1992;15(9):689-92.
1992: J van Wijngaarden; Stefan H J Monnink; H Bartels; Wiek H van Gilst; Pieter A de Graeff; CD De Langen; H Wesseling
Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.
Journal of cardiovascular pharmacology 1992;19(5):741-7.
1992: T J Tobé; CD De Langen; E G Weersink; J van Wijngaarden; Klaas J Bel; Pieter A de Graeff; Wiek H van Gilst; H Wesseling
The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs.
Journal of cardiovascular pharmacology 1992;19(5):732-40.
1992: J van Wijngaarden; T J Tobé; E G Weersink; Klaas J Bel; Pieter A de Graeff; CD De Langen; Wiek H van Gilst; H Wesseling
Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusion.
Journal of cardiovascular pharmacology 1992;19(3):408-16.
1992: René A Tio; CD De Langen; P H Mook; Klaas J Bel; G T Wolters; Wiek H van Gilst; Pieter A de Graeff; H Wesseling
Neurohumoral changes and the inducibility of ventricular tachycardias: effect of early reperfusion on the ischemic porcine myocardium.
Archives internationales de pharmacodynamie et de thérapie 1992;316():43-59.
1992: Wiek H van Gilst; René A Tio; J van Wijngaarden; Pieter A de Graeff; H Wesseling
Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
Journal of cardiovascular pharmacology 1992;19 Suppl 5():S134-9.
1991: Wiek H van Gilst; J Herre Kingma
Early intervention with angiotensin-converting enzyme inhibitors during thrombolytic therapy in acute myocardial infarction: rationale and design of captopril and thrombolysis study. CATS investigators group.
The American journal of cardiology 1991;68(14):111D-115D.
1991: J van Wijngaarden; Yigal M Pinto; Wiek H van Gilst; Pieter A de Graeff; CD De Langen; H Wesseling
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
Cardiovascular research 1991;25(11):936-42.
1991: S A van den Broek; A van Bruggen; Pieter A de Graeff; H Hillege; Wiek H van Gilst; H Wesseling; K I Lie
The acute hemodynamic, hormonal, and pharmacokinetic properties of oral spirapril in patients with moderate to severe heart failure.
Journal of cardiovascular pharmacology 1991;18(4):614-21.
1991: Wiek H van Gilst; Pieter A de Graeff; M J de Leeuw; Egbert Scholtens; H Wesseling
Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators.
Journal of cardiovascular pharmacology 1991;18(3):429-36.
1991: Harry J G M Crijns; Isabelle C Van Gelder; Wiek H van Gilst; H Hillege; A M Gosselink; K I Lie
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
The American journal of cardiology 1991;68(4):335-41.
1991: Isabelle C Van Gelder; Harry J G M Crijns; Wiek H van Gilst; R Verwer; K I Lie
Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.
The American journal of cardiology 1991;68(1):41-6.
1991: J van Wijngaarden; René A Tio; Wiek H van Gilst; Pieter A de Graeff; CD De Langen; H Wesseling
Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism.
Naunyn-Schmiedeberg's archives of pharmacology 1991;343(5):491-5.
1991: René A Tio; T J Tobé; Klaas J Bel; CD De Langen; Wiek H van Gilst; H Wesseling
Beneficial effects of bradykinin on porcine ischemic myocardium.
Basic research in cardiology 1991;86(2):107-16.
1991: Isabelle C Van Gelder; Harry J G M Crijns; Wiek H van Gilst; H P Hamer; K I Lie
Decrease of right and left atrial sizes after direct-current electrical cardioversion in chronic atrial fibrillation.
The American journal of cardiology 1991;67(1):93-5.
1991: Isabelle C Van Gelder; Harry J G M Crijns; Arnoud van der Laarse; Wiek H van Gilst; K I Lie
Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter.
American heart journal 1991;121(1 Pt 1):51-6.
1991: Yigal M Pinto; J van Wijngaarden; Wiek H van Gilst; Pieter A de Graeff; H Wesseling
The effects of short- and long-term treatment with an ACE-inhibitor in rats with myocardial infarction.
Basic research in cardiology 1991;86 Suppl 1():165-72.
1991: Dirk J van Veldhuisen; A R Girbes; Harry J G M Crijns; Andries J Smit; Wiek H van Gilst; K I Lie
The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.
International journal of clinical pharmacology research 1991;11(3):159-65.
1990: René A Tio; CD De Langen; Pieter A de Graeff; Wiek H van Gilst; Klaas J Bel; K G Wolters; P H Mook; J van Wijngaarden; H Wesseling
The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1990;4(3):695-703.
1990: L M van Wijk; Harry J G M Crijns; H J Kingma; Wiek H van Gilst; Isabelle C Van Gelder; H Wesseling; K I Lie
Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.
Journal of cardiovascular pharmacology 1990;15(6):884-91.
1990: J van Wijngaarden; René A Tio; Wiek H van Gilst; Pieter A de Graeff; CD De Langen; H Wesseling
Basic pharmacology of ACE-inhibitors with respect to ischaemic heart disease: prostaglandins and bradykinin.
European heart journal 1990;11 Suppl B():84-93.
1990: Maarten P van den Berg; J W Viersma; Wiek H van Gilst; K I Lie
Xamoterol in autonomic and intrinsic sinus node dysfunction.
The American journal of cardiology 1990;65(11):814-6.
1990: René A Tio; Wiek H van Gilst; Kristian Rett; K Wolters; G J Dietze; H Wesseling
The effects of bradykinin and the ischemic isolated rat heart.
Hormone and metabolic research. Supplement series 1990;22():85-9.
1989: René A Tio; J P Heiligers; CD De Langen; Wiek H van Gilst; W König; P R Saxena; H Wesseling
The haemodynamic effects of two angiotensin converting enzyme inhibitors, enalaprilat and zofenoprilat, in the rat: evidence for the involvement of bradykinin.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S296-7.
1989: Isabelle C Van Gelder; Harry J G M Crijns; Wiek H van Gilst; L M Van Wijk; H P Hamer; K I Lie
Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
The American journal of cardiology 1989;64(19):1317-21.
1989: H Wesseling; Pieter A de Graeff; Wiek H van Gilst; J H Kingma; C D de Langen
Cardiac arrhythmias--a new indication for angiotensin-converting enzyme inhibitors?
Journal of human hypertension 1989;3 Suppl 1():89-95.
1989: L M van Wijk; Harry J G M Crijns; Wiek H van Gilst; H Wesseling; K I Lie
Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
American heart journal 1989;117(2):365-9.
1989: CD De Langen; Pieter A de Graeff; Wiek H van Gilst; Klaas J Bel; J Herre Kingma; H Wesseling
Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig.
Journal of cardiovascular pharmacology 1989;13(2):186-91.
1989: René A Tio; J van Wijngaarden; Egbert Scholtens; Wiek H van Gilst; CD De Langen; H Wesseling
The increase in coronary flow induced by converting enzyme inhibitors is prostacyclin independent.
Progress in clinical and biological research 1989;301():435-9.
1989: Isabelle C Van Gelder; Harry J G M Crijns; Wiek H van Gilst; CD De Langen; L M Van Wijk; K I Lie
Effects of flecainide on the atrial defibrillation threshold.
The American journal of cardiology 1989;63(1):112-4.
1989: Wiek H van Gilst
Protection of the myocardium against postischemic reperfusion damage.
Journal of cardiovascular pharmacology 1989;14 Suppl 9():S49-54.
1989: L M van Wijk; P den Heijer; Harry J G M Crijns; Wiek H van Gilst; K I Lie
Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation.
Journal of cardiovascular pharmacology 1989;13(1):32-6.
1988: Wiek H van Gilst; J G Tijssen; G A van Es; J Lubsen
Serum potassium values in relation to the use of diuretics in patients with unstable angina pectoris.
European heart journal 1988;9(7):795-9.
1988: Wiek H van Gilst; Egbert Scholtens; Pieter A de Graeff; CD De Langen; H Wesseling
Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
Circulation 1988;77(6 Pt 2):I24-9.
1988: Harry J G M Crijns; L M van Wijk; Wiek H van Gilst; J Herre Kingma; Isabelle C Van Gelder; K I Lie
Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens.
European heart journal 1988;9(6):634-8.
1988: Isabelle C Van Gelder; Harry J G M Crijns; L M van Wijk; Wiek H van Gilst; K I Lie
Abnormal pharmacokinetics of flecainide in a "nonresponder".
Clinical cardiology 1988;11(5):353-5.
1988: P A deGraeff; C D deLangen; Wiek H van Gilst; Klaas J Bel; Egbert Scholtens; J Herre Kingma; H Wesseling
Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo.
The American journal of medicine 1988;84(3A):67-74.
1987: Wiek H van Gilst; Pieter A de Graeff; Egbert Scholtens; CD De Langen; H Wesseling
Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril.
Journal of cardiovascular pharmacology 1987;9(2):254-5.
1987: Pieter A de Graeff; Wiek H van Gilst; Klaas J Bel; C D de Langen; J Herre Kingma; H Wesseling
Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig model.
Journal of cardiovascular pharmacology 1987;9 Suppl 2():S37-42.
1987: Wiek H van Gilst; J van Wijngaarden; Egbert Scholtens; Pieter A de Graeff; CD De Langen; H Wesseling
Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?
Journal of cardiovascular pharmacology 1987;9 Suppl 2():S31-6.
1986: J W Viersma; Maarten P van den Berg; Wiek H van Gilst; K I Lie
Intrinsic sympathomimetic activity (ISA) of pindolol in patients with sinus node dysfunction.
European heart journal 1986;7(1):42-6.